Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v6-FR
Language English French
Date Updated 2018-01-20 2017-08-16
Drug Identification Number 02453460 02453460
Brand name APO-OLMESARTAN APO-OLMESARTAN
Common or Proper name OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL
Company Name APOTEX INC APOTEX INC
Ingredients OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL & 30 BLS 30 BLS
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-07-31 2017-07-31
Estimated end date 2018-01-22 2017-11-30
Actual end date 2018-01-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments APO-OLMESARTAN FCT 40MG 100 BTL available
Health Canada comments